The contraction inhibitor atosiban (Tractocile) was no better than placebo for neonatal outcomes in the context of threatened preterm birth, the investigators in the multicenter, randomized, ...
AURORA, Colo. -- Atosiban, an oxytocin receptor antagonist available in Europe, was not superior to placebo in improving neonatal outcomes for threatened preterm birth between 30 and 34 weeks' ...
Hosted on MSN
What to Know About Tocolytics for Preterm Labor
Tocolytics are short-term treatments used to allow time for interventions that can improve the outcomes of preterm labor and delivery for both mother and child. Since no single tocolytic drug is ...
New research from the University of Birmingham in collaboration with the World Health Organisation shows that tocolytic drugs used to delay preterm birth, and thus avert the ensuing associated ...
Women around the world should be able to access the best medical treatments that help to delay preterm births and improve neonatal outcomes, new research suggests. A new paper published in Cochrane ...
Women around the world should be able to access the best medical treatments that help to delay preterm births and improve neonatal outcomes, new research suggests. A new paper published in Cochrane ...
Fetal Well-Being Generally Fine After Strenuous Exercise The most effective tocolytic agents for delaying delivery and improving neonatal and maternal outcomes are prostaglandin inhibitors and calcium ...
Most pregnancies last about 40 weeks, but about one in eight births in the U.S. occur before the 37th week, when the fetus is not fully developed. Those preterm babies are more likely to have serious ...
To review the published literature on whether the use of empiric perioperative tocolytic medications could provide additional benefit when used in combination with cerclage. Only five publications on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results